Prediction of Future Weight Change With Dopamine Transporter

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03146429

Enrollment

200

Registered

2017-05-10

Start date

2017-01-01

Completion date

2017-04-15

Last updated

2018-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Change, Body

Brief summary

This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative

Interventions

DIAGNOSTIC_TESTI-123 FP-CIT Single photon emission tomography

Brain scan for dopamine transporter

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* males or females with their age of 30 years or older at screening

Exclusion criteria

* subjects with a neurological disorder, a first degree relative with idiopathic PD, Montreal Cognitive Assessment score of 26 or less, medications that might interfere with DAT SPECT scans, anticoagulants that might preclude safe completion of the lumbar puncture, or investigational drugs, and a condition that precludes the safe performance of routine lumbar puncture

Design outcomes

Primary

Measure	Time frame	Description
Weight change	1, 2, 3, 4, 5 year after SPECT	weight change per year until 5 years after SPECT

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026